- Published at
- by biznews.com
mixed
mixed
Optimi Health granted license to export psychedelics to Australia
Canada has licensed Optimi Health to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelics market.
News for AWAKN LIFE SCIENCES CORP. (AWKN.NE)
- Published at
- by financialpost.com
mixedmixed- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Corp. (AWKN)
Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. ...- Published at
- by marketscreener.com
neutralneutralAwakn Life Sciences Discusses Filing of Financial Statements
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , announces that, it...- Published at
- by marketscreener.com
positivepositiveCSE Bulletin: New Listing - Awakn Life Sciences Corp. (AWKN) -February 12, 2024 at 01:55 pm EST
The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. ...- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Announces Listing on the Canadian Securities Exchange
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , is pleased to announce...- Published at
- by investorideas.com
positivepositiveCSE Biotech Listing - Awakn Life Sciences Corp. (CSE: AWKN)
February 9, 2024 (Investorideas.com Newswire) The common shares of Awakn Life Sciences Corp. have been approved for listing on the CSE. Listing and disclosure ...- Published at
- by investorideas.com
positivepositiveBiotech Stock Awakn Life Sciences (CBOE: AWKN) (OTCQB: AWKNF) Completes Successful Investigative Study
Toronto, Ontario - January 24, 2024 (Newsfile Corp.) (Investorideas.com Newswire) Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a ...- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder , is pleased to announce...- Published at
- by marketscreener.com
positivepositiveAwakn Life Sciences Provides Corporate Update
Awakn Life Sciences Corp. , a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder , shares a corporate update on recent...- Published at
- by benzinga.com
mixedmixedPsyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS - ATA (ATAI), Cybin Inc. Common Shares (CYBN), FIELD TRIP HEALTH CM (FTRP)
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: